Fingerpaint Group

Fingerpaint Group is a privately held, full-service healthcare marketing and commercialization agency specializing in the life sciences industry. Founded in 2008, the company's core mission is to deliver integrated, analytics-enabled solutions, driven by deep human and scientific insights, to address business and human challenges within healthcare. Headquartered in Cedar Knolls, New Jersey, Fingerpaint Group aims to provide transformative healthcare solutions, operating under the philosophy of "never painting by number."

The company offers a comprehensive suite of services, including integrated marketing, medical communications, market access consultancy, branding, multicultural marketing, media and activation, and medical affairs. Fingerpaint Group serves a diverse range of market segments, including biopharma, biotech, medical devices, and animal health, partnering with a significant number of the top global pharmaceutical companies.

Under the leadership of CEO Bill McEllen, who succeeded founder Ed Mitzen (now an active board member), Fingerpaint Group has established itself as a top 20 healthcare agency. The company closed 2025 with record revenue and has been consistently recognized on the Inc. 5000 list of fastest-growing private companies for a decade. Recent strategic moves include the unification of its various solutions under the Fingerpaint brand, such as Fingerpaint Medical and Fingerpaint Branding, and several acquisitions, including L&M Healthcare Communications, MedThink, Emcay, and BlackPoint Consulting Group, to expand its capabilities. The firm emphasizes a human-led, AI-enabled approach to innovation, particularly in high-growth therapeutic areas like oncology, immunology, and neurology.